SARS-CoV-2 S protein: ACE2 interaction reveals novel allosteric targets

…, NK Tulsian, F Samsudin, X Qian, K Purushotorman… - Elife, 2021 - elifesciences.org
The Spike (S) protein is the main handle for SARS-CoV-2 to enter host cells via surface ACE2
receptors. How ACE2 binding activates proteolysis of S protein is unknown. Here, using …

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the …

…, S Guan, D Thakkar, GH Teo, K Purushotorman… - PLoS …, 2021 - journals.plos.org
Although SARS-CoV-2-neutralizing antibodies are promising therapeutics against COVID-19,
little is known about their mechanism(s) of action or effective dosing windows. We report …

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies

…, X Qian, MM Kozma, K Purushotorman… - Communications …, 2021 - nature.com
Background Neutralizing antibodies (NAbs) prevent pathogens from infecting host cells.
Detection of SARS-CoV-2 NAbs is critical to evaluate herd immunity and monitor vaccine …

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis

…, R Bouzeyen, B Shunmuganathan, K Purushotorman… - npj Vaccines, 2023 - nature.com
Tuberculosis (TB) is an airborne disease caused by Mycobacterium tuberculosis (Mtb). Whilst
a functional role for humoral immunity in Mtb protection remains poorly defined, previous …

Defining the structural basis for human alloantibody binding to human leukocyte antigen allele HLA-A* 11: 01

…, TM Murali, J Yap, CT Too, K Purushotorman… - Nature …, 2019 - nature.com
Our understanding of the conformational and electrostatic determinants that underlie targeting
of human leukocyte antigens (HLA) by anti-HLA alloantibodies is principally based upon …

Defining the specificity and function of a human neutralizing antibody for Hepatitis B virus

S Jhajharia, F Lai, HB Low, K Purushotorman… - npj Vaccines, 2022 - nature.com
Hepatitis B Virus (HBV) is a hepadnavirus that is the principal pathogen underlying viral liver
disease in human populations. In this study, we describe the isolation and characterization …

Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vaccines

…, Y Wang, Y Gu, X Qian, ISL Tan, K Purushotorman… - npj Vaccines, 2024 - nature.com
The advent of SARS-CoV-2 variants with defined mutations that augment pathogenicity and/or
increase immune evasiveness continues to stimulate global efforts to improve vaccine …

Employment of a high throughput functional assay to define the critical factors that influence vaccine induced cross-variant neutralizing antibodies for SARS-CoV-2

…, R Gupta, RSW Tan, M Kozma, K Purushotorman… - Scientific Reports, 2023 - nature.com
The scale and duration of neutralizing antibody responses targeting SARS-CoV-2 viral variants
represents a critically important serological parameter that predicts protective immunity …

Relative deficiency in interferon‐γ‐secreting CD4+ T cells is strongly associated with poorer COVID‐19 vaccination responses in older adults

…, R Gupta, NYJ Tan, X Qian, K Purushotorman… - Aging …, 2024 - Wiley Online Library
Although the two‐dose mRNA vaccination regime provides protection against SARS‐CoV‐2,
older adults have been shown to exhibit poorer vaccination responses. In addition, the role …

Defining Factors that Influence vaccine-induced, cross-variant neutralizing antibodies for SARS-CoV-2 in Asians

…, R Gupta, RSW Tan, M Kozma, K Purushotorman… - medRxiv, 2022 - medrxiv.org
The scale and duration of neutralizing antibody responses targeting SARS-CoV-2 viral variants
represents a critically important serological parameter that predicts protective immunity …